Advanced invasomal delivery system for enhanced topical application of bifonazole in fungal infections
DOI:
https://doi.org/10.56782/pps.317Keywords:
Invasomes, Bifonazole, Drug Encapsulation, Skin Penetration, Response Surface MethodologyAbstract
The design and development of invasomes containing bifonazole for effective topical fungal treatment was investigated to improve the bioavailability and therapeutic efficacy of this antifungal agent. Invasomes, novel lipid-based vesicular systems, were formulated to enhance skin penetration and provide sustained drug release, thereby increasing the local concentration of bifonazole at the site of infection. The formulation was optimized using response surface methodology (RSM), where various factors such as phosphatidylcholine, terpenes, and ethanol were varied to evaluate their effects on entrapment efficiency, vesicle size, and drug release characteristics. The optimized invasomal formulation demonstrated high entrapment efficiency (~74.12%) and an average vesicle size of 154.45 nm, suitable for effective skin penetration. In vitro release studies revealed sustained drug release from the invasomes, with a slower release profile compared to the plain drug. The optimized formulation exhibited enhanced antifungal activity, suggesting that invasomes could serve as a promising carrier for the topical delivery of bifonazole, offering a potential solution for treating superficial fungal infections with improved efficacy and patient compliance.
Downloads
References
1. Kaur, I.P.; Kakkar, S. Topical delivery of antifungal agents. Expert Opin. Drug Deliv. 2010, 7(11), 1303–1327. DOI: 10.1517/17425247.2010.525230 DOI: https://doi.org/10.1517/17425247.2010.525230
2. Wu, S., Song, R., Liu, T. & Li, C. Antifungal therapy: Novel drug delivery strategies driven by new targets. Adv. Drug Deliv. Rev. 2023, 199, Art. No: 114967. DOI: 10.1016/j.addr.2023.114967 DOI: https://doi.org/10.1016/j.addr.2023.114967
3. Rani, N.; Sharma, A.; Gupta, G.K.; Singh, R. Imidazoles as potential antifungal agents: A review. Mini Rev. Med. Chem. 2013, 13, 1626–1655. DOI: 10.2174/13895575113139990069 DOI: https://doi.org/10.2174/13895575113139990069
4. Mathur, M.; Devi, V.K. Potential of novel drug delivery systems in the management of topical candidiasis. J. Drug Target 2017, 25, 685–703. DOI: 10.1080/1061186X.2017.1331352 DOI: https://doi.org/10.1080/1061186X.2017.1331352
5. Jain, S.; Tripathi, S.; Tripathi, P.K. Invasomes: Potential vesicular systems for transdermal delivery of drug molecules. J. Drug Deliv. Sci. Technol. 2021, 61, Art. No: 102166. DOI: 10.1016/j.jddst.2020.102166.
6. Akhtar, N.; Verma, A.; Pathak, K.Topical delivery of drugs for the effective treatment of fungal infections of skin. Curr. Pharm. Des. 2015, 21, 2892–2913. DOI: 10.2174/1381612821666150428150456. DOI: https://doi.org/10.2174/1381612821666150428150456
7. Nangare, S.; Dugam, S. Smart invasome synthesis, characterizations, pharmaceutical applications, and pharmacokinetic perspective: A review. Futur. J. Pharm. Sci. 2020, 6, Art. No :123. DOI: 10.1186/s43094-020-00145-8 DOI: https://doi.org/10.1186/s43094-020-00145-8
8. Gaynanova, G., Vasileva, L., Kashapov, R., Kuznetsova, D., Kushnazarova, R., Tyryshkina, A., Vasilieva, E., Petrov, K., Zakharova, L. & Sinyashin, O. Self-assembling drug formulations with tunable permeability and biodegradability. Molecules 2021, 26, Art. No: 6786 DOI:10.3390/molecules26226786 DOI: https://doi.org/10.3390/molecules26226786
9. Albash, R.; Al-Mahallawi, A.M.; Hassan, M.; Alaa-Eldin, A.A. Development and optimization of terpene-enriched vesicles (Terpesomes) for effective ocular delivery of fenticonazole nitrate: in vitro characterization and in vivo assessment. Int. J. Nanomed. 2021, 16, 609-621. DOI: 10.2147/IJN.S274290 DOI: https://doi.org/10.2147/IJN.S274290
10. Walbi, I.A.; Ahmad, M.Z.; Ahmad, J.; Algahtani, M.S., Alali, A.S.; Alsudi, S.A.; Aodah, A.H.; Albarqi, H.A. Development of a curcumin-loaded lecithin/chitosan nanoparticle utilizing a box-behnken design of experiment: formulation design and influence of process parameters. Polymers 2022, 14, Art. No: 3758. DOI: 10.3390/polym14183758 DOI: https://doi.org/10.3390/polym14183758
11. Alhalmi, A.; Amin, S.; Beg,.S.; Al-Salahi; R.; Mir,.S.R., Kohli, K. Formulation and optimization of naringin loaded nanostructured lipid carriers using Box-Behnken based design: In vitro and ex vivo evaluation. J. Drug Deliv. Sci. Technol. 2022, 74, Art. No: 103590. DOI: 10.1016/j.jddst.2022.103590 DOI: https://doi.org/10.1016/j.jddst.2022.103590
12. Sala, M.;. Elaissari, A.; Fessi, H. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS). J. Control. Rel. 2016, 239, 182–202. DOI: 10.1016/j.jconrel.2016.07.003 DOI: https://doi.org/10.1016/j.jconrel.2016.07.003
13. Dragicevic-Curic, N.; Gräfe, S.; Gitter, B.; Fahr, A. Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines. J. Photochem. Photobiol. B, Biol. 2010, 101, 238–250. DOI: 10.1016/j.jphotobiol.2010.07.009 DOI: https://doi.org/10.1016/j.jphotobiol.2010.07.009
14. Sailaja, A.K.; Kirthi, R. Ethosomes and invasomes-A Vesicular Drug delivery carrier and their applications in transdermal drug delivery systems. Pharm. Pharmacol. Res. 2024, 7, 158. DOI: 10.31579/2688-7517/158
15. Raina, N., Rani R., Thakur V.K., Gupta M. New insights in topical drug delivery for skin disorders: from a nanotechnological perspective. ACS omega 2023, 8, 19145-19167. DOI: 1021/acsomega.2c08016 DOI: https://doi.org/10.1021/acsomega.2c08016
16. Samir,.B.; El-Kamel,.A.; Zahran,.N.; Heikal,.L. Resveratrol-loaded invasome gel: A promising nanoformulation for treatment of skin cancer. Drug Deliv. Transl. Res. 2024, 14, 3354-3370. DOI: 10.1007/s13346-024-01534-9 DOI: https://doi.org/10.1007/s13346-024-01534-9
17. Teaima, M.H.; Eltabeeb, M.A.; El-Nabarawi, M.A., Abdellatif, M.M. Utilization of propranolol hydrochloride mucoadhesive invasomes as a locally acting contraceptive: In-vitro, ex-vivo, and in-vivo evaluation. Drug Deliv. 2022, 29(1), 2549–2560. DOI: 10.1080/10717544.2022.2100514 DOI: https://doi.org/10.1080/10717544.2022.2100514
18. Badran, M.M.; Kuntsche, J.; Fahr, A. Skin penetration enhancement by a microneedle device (Dermaroller®) in vitro: Dependency on needle size and applied formulation. Eur. J. Pharm. Sci. 2009, 36, 511–523. DOI: 10.1016/j.ejps.2008.12.008, DOI: https://doi.org/10.1016/j.ejps.2008.12.008
19. Cunha, I.V; Campos, A.M.; Gerola, A.P.; Caon, T. Effect of invasome composition on membrane fluidity, vesicle stability and skin interactions. Int. J. Pharm. 2023, 646, Art. No: 123472. DOI: 10.1016/j.ijpharm.2023.123472 DOI: https://doi.org/10.1016/j.ijpharm.2023.123472
20. Jain,.S.; Tripathi,.S.;.Tripathi,.P.K., Invasomes: Potential vesicular systems for transdermal delivery of drug molecules. J. Drug Deliv. Sci. Technol. 2021, 61, Art. No: 102166. DOI: 10.1016/j.jddst.2020.102166 DOI: https://doi.org/10.1016/j.jddst.2020.102166
21. El-Kayal, M.; Hatem, S., A comparative study between nanostructured lipid carriers and invasomes for the topical delivery of luteolin: Design, optimization and pre-clinical investigations for psoriasis treatment. J. Drug Deliv. Sci. Technol. 2024, 97, Art. No: 105740. DOI: 10.1016/j.jddst.2024.105740 DOI: https://doi.org/10.1016/j.jddst.2024.105740
22. Salem, H.F.; Gamal, A.; Saeed, H.; Kamal, M.; Tulbah, A.S. Enhancing the bioavailability and efficacy of vismodegib for the control of skin cancer: in vitro and in vivo studies. Pharmaceuticals 2022, 15(2), Art. No: 126. DOI: 10.3390/ph15020126 DOI: https://doi.org/10.3390/ph15020126
23. Dragicevic-Curic, N.; Scheglmann, D.; Albrecht, V.; Fahr, A. Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies. J. Control. Rel. 2008, 127, 59–69. DOI: 10.1016/j.jconrel.2007.12.013 DOI: https://doi.org/10.1016/j.jconrel.2007.12.013
24. RefeKumar, B.; Sahoo, P.K.; Manchanda, S. Formulation, characterization and ex vivo study of curcumin nano-invasomal gel for enhanced transdermal delivery. OpenNano 2022, 7, Art. No: 100058. DOI: 10.1016/j.onano.2022.100058 DOI: https://doi.org/10.1016/j.onano.2022.100058
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Shivaji Patil, Sushil Bhargav
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
